Recent advances in natural products from plants for treatment of liver diseases

European Journal of Medicinal Chemistry

Volumn 63, Issue , 2013, Pages 570-577

  Zhang, Aihua ^a   Sun, Hui ^a   Wang, Xijun ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Drug discovery; Hepatoprotective; Liver diseases; Natural products; Secondary metabolites

Indexed keywords

ARTEMISININ; CURCUMIN; ELLAGIC ACID; GENIPOSIDE; GLYCYRRHIZIC ACID; MATRINE; MELLEIN; NARINGENIN; RESVERATROL; RHEIN; SCOPARONE; SILYMARIN; UNCLASSIFIED DRUG; WOGONIN;

DRUG STRUCTURE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER DISEASE; NONHUMAN; REVIEW; TRANSLATIONAL RESEARCH;

EID: 84875913089     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.12.062     Document Type: Short Survey

References (90)

1. B.B. Mishra, and V.K. Tiwari Natural products: an evolving role in future drug discovery Eur. J. Med. Chem. 46 10 2011 4769 4807
2. M. Gao, R.E. Nettles, M. Belema, L.B. Snyder, V.N. Nguyen, R.A. Fridell, M.H. Serrano-Wu, D.R. Langley, J.H. Sun, D.R. O'Boyle 2nd, J.A. Lemm, C. Wang, J.O. Knipe, C. Chien, R.J. Colonno, D.M. Grasela, N.A. Meanwell, and L.G. Hamann Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect Nature 465 7294 2010 96 100
3. I. Paterson, and E.A. Anderson Chemistry. The renaissance of natural products as drug candidates Science 310 5747 2005 451 453
4. E.L. Teuten, L. Xu, and C.M. Reddy Two abundant bioaccumulated halogenated compounds are natural products Science 307 5711 2005 917 920
5. J.M. Rollinger, T. Langer, and H. Stuppner Strategies for efficient lead structure discovery from natural products Curr. Med. Chem. 13 13 2006 1491 1507
6. R. Majeed, M.V. Reddy, P.K. Chinthakindi, P.L. Sangwan, A. Hamid, G. Chashoo, A.K. Saxena, and S. Koul Bakuchiol derivatives as novel and potent cytotoxic agents: a report Eur. J. Med. Chem. 49 2012 55 67
7. D. López, M.A. Fischbach, F. Chu, R. Losick, and R. Kolter Structurally diverse natural products that cause potassium leakage trigger multicellularity in Bacillus subtilis Proc. Natl. Acad. Sci. U S A 106 1 2009 280 285
8. E. Sala, L. Guasch, J. Iwaszkiewicz, M. Mulero, M.J. Salvadó, C. Bladé, M. Ceballos, C. Valls, V. Zoete, A. Grosdidier, S. Garcia-Vallvé, O. Michielin, and G. Pujadas Identification of human IKK-2 inhibitors of natural origin (Part II): in Silico prediction of IKK-2 inhibitors in natural extracts with known anti-inflammatory activity Eur. J. Med. Chem. 46 12 2011 6098 6103
9. M.M. Ghorab, F.A. Ragab, H.I. Heiba, and R.M. El-Hazek Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety Eur. J. Med. Chem. 46 10 2011 5120 5126
10. V. Ravichandiran, K. Shanmugam, K. Anupama, S. Thomas, and A. Princy Structure-based virtual screening for plant-derived SdiA-selective ligands as potential antivirulent agents against uropathogenic Escherichia coli Eur. J. Med. Chem. 48 2012 Feb 200 205
11. C. Girish, and S.C. Pradhan Drug development for liver diseases: focus on picroliv, ellagic acid and curcumin Fundam. Clin. Pharmacol. 22 6 2008 623 632
12. K.V. Sashidhara, S.P. Singh, A. Srivastava, A. Puri, Y.S. Chhonker, R.S. Bhatta, P. Shah, and M.I. Siddiqi Discovery of a new class of HMG-CoA reductase inhibitor from Polyalthia longifolia as potential lipid lowering agent Eur. J. Med. Chem. 46 10 2011 5206 5211
13. N. Qin, C.B. Li, M.N. Jin, L.H. Shi, H.Q. Duan, and W.Y. Niu Synthesis and biological activity of novel tiliroside derivants Eur. J. Med. Chem. 46 10 2011 5189 5195
14. X. Wang, A. Zhang, and H. Sun Future perspectives of Chinese medical formulae: chinmedomics as an effector OMICS 16 2012 414 421
15. N. Nazir, S. Koul, M.A. Qurishi, M.H. Najar, and M.I. Zargar Evaluation of antioxidant and antimicrobial activities of Bergenin and its derivatives obtained by chemoenzymatic synthesis Eur. J. Med. Chem. 46 6 2011 2415 2420
16. C. Wohlfarth, and T. Efferth Natural products as promising drug candidates for the treatment of hepatitis B and C Acta. Pharmacol. Sin. 30 1 2009 25 30
17. B. Patwardhan, and A.D. Vaidya Natural products drug discovery: accelerating the clinical candidate development using reverse pharmacology approaches Indian. J. Exp. Biol. 48 3 2010 220 227
18. G. Bringmann, R. Brun, M. Kaiser, and S. Neumann Synthesis and antiprotozoal activities of simplified analogs of naphthylisoquinoline alkaloids Eur. J. Med. Chem. 43 1 2008 32 42
19. P.K. Sahoo, and P. Behera Synthesis and biological screening of some novel amidocarbamate derivatives of ketoprofen Eur. J. Med. Chem. 45 7 2010 3162 3168
20. C.L. Murray, and C.M. Rice Hepatitis C: an unsuspected drug target Nature 465 7294 2010 42 44
21. C. Loguercio, and D. Festi Silybin and the liver: from basic research to clinical practice World. J. Gastroenterol. 17 18 2011 2288 2301
22. G.Z. Zeng, X.L. Pan, N.H. Tan, J. Xiong, and Y.M. Zhang Natural biflavones as novel inhibitors of cathepsin B and K Eur. J. Med. Chem. 41 11 2006 1247 1252
23. Q. Guo, L. Zhao, Q. You, Y. Yang, H. Gu, G. Song, N. Lu, and J. Xin Anti-hepatitis B virus activity of wogonin in vitro and in vivo Antiviral. Res. 74 1 2007 16 24
24. Y.C. Chen, S.C. Shen, W.R. Lee, H.Y. Lin, C.H. Ko, C.M. Shih, and L.L. Yang Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1 Arch. Toxicol. 76 5-6 2002 351 359
25. L. Pari, D. Tewas, and J. Eckel Role of curcumin in health and disease Arch. Physiol. Biochem. 114 2 2008 127 449
26. Y. Rivera-Espinoza, and P. Muriel Pharmacological actions of curcumin in liver diseases or damage Liver Int. 29 10 2009 1457 1466
27. U.A. Ashfaq, M.S. Masoud, Z. Nawaz, and S. Riazuddin Glycyrrhizin as antiviral agent against hepatitis C virus J. Transl. Med. 9 2011 112
28. X.Y. Wan, M. Luo, X.D. Li, and P. He Hepatoprotective and anti-hepatocarcinogenic effects of glycyrrhizin and matrine Chem. Biol. Interact. 181 1 2009 15 19
29. K. Abe, T. Ikeda, K. Wake, T. Sato, T. Sato, and H. Inoue Glycyrrhizin prevents of lipopolysaccharide/D-galactosamine- induced liver injury through down-regulation of matrix metalloproteinase-9 in mice J. Pharm. Pharmacol. 60 1 2008 91 97
30. B. Tang, H. Qiao, F. Meng, and X. Sun Glycyrrhizin attenuates endotoxin- induced acute liver injury after partial hepatectomy in rats Braz. J. Med. Biol. Res. 40 12 2007 1637 1646
31. M. Ogiku, H. Kono, M. Hara, M. Tsuchiya, and H. Fujii Glycyrrhizin prevents liver injury by inhibition of high-mobility group box 1 production by Kupffer cells after ischemia-reperfusion in rats J. Pharmacol. Exp. Ther. 339 1 2011 93 98
32. N. Tsuruoka, K. Abe, K. Wake, M. Takata, A. Hatta, T. Sato, and H. Inoue Hepatic protection by glycyrrhizin and inhibition of iNOS expression in concanavalin A-induced liver injury in mice Inflamm. Res. 58 9 2009 Sep 593 599
33. C.H. Lee, S.W. Park, Y.S. Kim, S.S. Kang, J.A. Kim, S.H. Lee, and S.M. Lee Protective mechanism of glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice Biol. Pharm. Bull. 30 10 2007 1898 1904
34. J.M. Smoliga, J.A. Baur, and H.A. Hausenblas Resveratrol and health-a comprehensive review of human clinical trials Mol. Nutr. Food. Res. 55 8 2011 1129 1141
35. C.C. Chan, L.Y. Cheng, C.L. Lin, Y.H. Huang, H.C. Lin, and F.Y. Lee The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injury Mol. Nutr. Food. Res. 55 12 2011 1841 1849
36. S. Roy, S. Sannigrahi, S. Majumdar, B. Ghosh, and B. Sarkar Resveratrol regulates antioxidant status, inhibits cytokine expression and restricts apoptosis in carbon tetrachloride induced rat hepatic injury Oxid. Med. Cell. Longev. 2011 2011 703676
37. D. Rajasekaran, J. Elavarasan, M. Sivalingam, E. Ganapathy, A. Kumar, K. Kalpana, and D. Sakthisekaran Resveratrol interferes with N-nitrosodiethylamine- induced hepatocellular carcinoma at early and advanced stages in male Wistar rats Mol. Med. Rep. 4 6 2011 1211 1217
38. H.B. Yu, H.F. Zhang, X. Zhang, D.Y. Li, H.Z. Xue, C.E. Pan, and S.H. Zhao Resveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF-kappa B-mediated mechanism Hepatogastroenterology 57 102-103 2010 1241 1246
39. T. Tunali-Akbay, O. Sehirli, F. Ercan, and G. Sener Resveratrol protects against methotrexate-induced hepatic injury in rats J. Pharm. Pharm. Sci. 13 2 2010 303 310
40. E.S. Lee, M.O. Shin, S. Yoon, and J.O. Moon Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in rats Arch. Pharm. Res. 33 6 2010 925 932
41. S.W. Hong, K.H. Jung, H.M. Zheng, H.S. Lee, J.K. Suh, I.S. Park, D.H. Lee, and S.S. Hong The protective effect of resveratrol on dimethylnitrosamine- induced liver fibrosis in rats Arch. Pharm. Res. 33 4 2010 601 609
42. A. Rašković, N. Stilinović, J. Kolarović, V. Vasović, S. Vukmirović, and M. Mikov The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats Molecules 16 10 2011 8601 8613
43. S.J. Polyak, C. Morishima, V. Lohmann, S. Pal, D.Y. Lee, Y. Liu, T.N. Graf, and N.H. Oberlies Identification of hepatoprotective flavonolignans from silymarin Proc. Natl. Acad. Sci. U S A 107 13 2010 Mar 30 5995 5999
44. M. Muthumani, and S.M. Prabu Silibinin potentially protects arsenic-induced oxidative hepatic dysfunction in rats Toxicol. Mech. Methods. 22 4 2012 277 288
45. I.S. Chen, Y.C. Chen, C.H. Chou, R.F. Chuang, L.Y. Sheen, and C.H. Chiu Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis J. Sci. Food. Agric. 92 7 2012 1441 1447
46. J. Féher, and G. Lengyel Silymarin in the prevention and treatment of liver diseases and primary liver cancer Curr. Pharm. Biotechnol. 13 1 2012 210 217
47. M.H. Lee, S. Yoon, and J.O. Moon The flavonoid naringenin inhibits dimethylnitrosamine-induced liver damage in rats Biol. Pharm. Bull. 27 1 2004 72 76
48. L. Pari, and M. Gnanasoundari Influence of naringenin on oxytetracycline mediated oxidative damage in rat liver Basic. Clin. Pharmacol. Toxicol. 98 5 2006 456 461
49. J. Renugadevi, and S.M. Prabu Cadmium-induced hepatotoxicity in rats and the protective effect of naringenin Exp. Toxicol. Pathol. 62 2 2010 171 181
50. J. Jayaraman, M. Veerappan, and N. Namasivayam Potential beneficial effect of naringenin on lipid peroxidation and antioxidant status in rats with ethanol-induced hepatotoxicity J. Pharm. Pharmacol. 61 10 2009 1383 1390
51. K. Kojima, T. Shimada, Y. Nagareda, M. Watanabe, J. Ishizaki, Y. Sai, K. Miyamoto, and M. Aburada Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells Biol. Pharm. Bull. 34 10 2011 1613 1618
52. T. Ma, C. Huang, G. Zong, D. Zha, X. Meng, J. Li, and W. Tang Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis J. Pharm. Pharmacol. 63 4 2011 587 593
53. B.C. Kim, H.G. Kim, S.A. Lee, S. Lim, E.H. Park, S.J. Kim, and C.J. Lim Genipin-induced apoptosis in hepatoma cells is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of mitochondrial pathway Biochem. Pharmacol. 70 9 2005 1398 1407
54. P. Shi, Z. Huang, and G. Chen Rhein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma BEL-7402 cells Am. J. Chin. Med. 36 4 2008 805 813
55. X. Sheng, M. Wang, M. Lu, B. Xi, H. Sheng, and Y.Q. Zang Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice Am. J. Physiol. Endocrinol. Metab. 300 5 2011 E886 E893
56. Y.L. Zhao, G.D. Zhou, H.B. Yang, J.B. Wang, L.M. Shan, R.S. Li, and X.H. Xiao Rhein protects against acetaminophen-induced hepatic and renal toxicity Food. Chem. Toxicol. 49 8 2011 1705 1710
57. M.Z. Guo, X.S. Li, H.R. Xu, Z.C. Mei, W. Shen, and X.F. Ye Rhein inhibits liver fibrosis induced by carbon tetrachloride in rats Acta. Pharmacol. Sin. 23 8 2002 739 744
58. X. Wang, H. Sun, A. Zhang, G. Jiao, W. Sun, and Y. Yuan Pharmacokinetics screening for multi-components absorbed in the rat plasma after oral administration traditional Chinese medicine formula Yin-Chen-Hao-Tang by ultra performance liquid chromatography-electrospray ionization/quadrupole-time-of- flight mass spectrometry combined with pattern recognition methods Analyst 136 23 2011 5068 5076
59. F. Zhang, X. Wang, L. Tong, H. Qiao, X. Li, L. You, H. Jiang, and X. Sun Matrine attenuates endotoxin-induced acute liver injury after hepatic ischemia/reperfusion in rats Surg. Today. 41 8 2011 1075 1084
60. H.B. Yu, H.F. Zhang, D.Y. Li, X. Zhang, H.Z. Xue, and S.H. Zhao Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells J. Asian. Nat. Prod. Res. 13 3 2011 242 250 PMID:21409686
61. K.C. Thresiamma, and R. Kuttan Inhibition of liver fibrosis by ellagic acid Indian. J. Physiol. Pharmacol. 1996
62. G.H. Buniatian Stages of activation of hepatic stellate cells: effects of ellagic acid, an inhibiter of liver fibrosis, on their differentiation in culture Cell. Prolif. 36 6 2003 307 319
63. T. Noshita, Y. Kidachi, H. Funayama, H. Kiyota, H. Yamaguchi, and K. Ryoyama Anti-nitric oxide production activity of isothiocyanates correlates with their polar surface area rather than their lipophilicity Eur. J. Med. Chem. 44 12 2009 4931 4936
64. S.S. Lamb, and G.D. Wright Accessorizing natural products: adding to nature's toolbox Proc. Natl. Acad. Sci. U S A 102 3 2005 519 520
65. L.H. Cazarolli, P. Folador, H.H. Moresco, I.M. Brighente, M.G. Pizzolatti, and F.R. Silva Stimulatory effect of apigenin-6-C-beta-L- fucopyranoside on insulin secretion and glycogen synthesis Eur. J. Med. Chem. 44 11 2009 4668 4673
66. N. Ghosh, R. Ghosh, V. Mandal, and S.C. Mandal Recent advances in herbal medicine for treatment of liver diseases Pharm. Biol. 49 9 2011 970 988
67. A.C. Pinto, L.F. Silva, B.C. Cavalcanti, M.R. Melo, F.C. Chaves, L.V. Lotufo, M.O. de Moraes, V.F. de Andrade-Neto, W.P. Tadei, C.O. Pessoa, P.P. Vieira, and A.M. Pohlit New antimalarial and cytotoxic 4-nerolidylcatechol derivatives Eur. J. Med. Chem. 44 6 2009 2731 2735
68. Z.X. Cao, Z.F. Zhao, and X.F. Zhao Effect of compound glycyrrhizin injection on liver function and cellular immunity of children with infectious mononucleosis complicated liver impairment Chin. J. Integr. Med. 12 4 2006 268 272
69. K. Ikeda, Y. Arase, M. Kobayashi, S. Saitoh, T. Someya, T. Hosaka, H. Sezaki, N. Akuta, Y. Suzuki, F. Suzuki, and H. Kumada A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients Dig. Dis. Sci. 51 3 2006 603 609
70. Y. Long, X.T. Lin, K.L. Zeng, and L. Zhang Efficacy of intramuscular matrine in the treatment of chronic hepatitis B Hepatobiliary. Pancreat. Dis. Int. 3 1 2004 69 72
71. Y. Lao Clinical study on effect of matrine injection to protect the liver function for patients with primary hepatic carcinoma after trans-artery chemo-embolization (TAE) Zhong. Yao. Cai. 28 7 2005 637 638
72. J.P. Zhang, M. Zhang, J.P. Zhou, F.T. Liu, B. Zhou, W.F. Xie, and C. Guo Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats Acta. Pharmacol. Sin. 22 2 2001 183 186
73. A. Zhang, H. Sun, P. Wang, Y. Han, and X. Wang Metabonomics for discovering biomarkers of hepatotoxicity and nephrotoxicity Pharmazie 67 2 2012 99 105
74. M. Ispikoudi, M. Amvrazis, C. Kontogiorgis, A.E. Koumbis, K.E. Litinas, D. Hadjipavlou-Litina, and K.C. Fylaktakidou Convenient synthesis and biological profile of 5-amino-substituted 1,2,4-oxadiazole derivatives Eur. J. Med. Chem. 45 12 2010 5635 5645
75. M.B. Sporn, K.T. Liby, M.M. Yore, L. Fu, J.M. Lopchuk, and G.W. Gribble New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress J. Nat. Prod. 74 3 2011 Mar 25 537 545
76. M.A. Koch, A. Schuffenhauer, M. Scheck, S. Wetzel, M. Casaulta, A. Odermatt, P. Ertl, and H. Waldmann Charting biologically relevant chemical space: a structural classification of natural products (SCONP) Proc. Natl. Acad. Sci. U S A 102 48 2005 17272 17277
77. I. Ojima, S. Chakravarty, T. Inoue, S. Lin, L. He, S.B. Horwitz, S.D. Kuduk, and S.J. Danishefsky A common pharmacophore for cytotoxic natural products that stabilize microtubules Proc. Natl. Acad. Sci. U S A 96 8 1999 4256 4261
78. A. García, V. Bocanegra-García, J.P. Palma-Nicolás, and G. Rivera Recent advances in antitubercular natural products Eur. J. Med. Chem. 49 2012 1 23
79. S.L. Robinette, R. Brüschweiler, F.C. Schroeder, and A.S. Edison NMR in metabolomics and natural products research: two sides of the same coin Acc. Chem. Res. 45 2 2012 288 297
80. M.B. Fernandes, M.T. Scotti, M.J. Ferreira, and V.P. Emerenciano Use of self-organizing maps and molecular descriptors to predict the cytotoxic activity of sesquiterpene lactones Eur. J. Med. Chem. 43 10 2008 2197 2205
81. X. Wang, H. Sun, A. Zhang, W. Sun, P. Wang, and Z. Wang Potential role of metabolomics approaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine J. Pharm. Biomed. Anal. 55 5 2011 859 868
82. A. Zhang, H. Sun, Z. Wang, W. Sun, P. Wang, and X. Wang Metabolomics: towards understanding traditional Chinese medicine Planta. Med. 76 17 2010 2026 2035
83. H. Sun, B. Ni, A. Zhang, M. Wang, H. Dong, and X. Wang Metabolomics study on Fuzi and its processed products using ultra-performance liquid- chromatography/electrospray-ionization synapt high-definition mass spectrometry coupled with pattern recognition analysis Analyst 137 1 2012 170 185
84. B. Yang, A. Zhang, H. Sun, W. Dong, G. Yan, T. Li, and X. Wang Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid-chromatography/electrospray-ionization synapt high- definition mass spectrometry J. Pharm. Biomed. Anal. 58 2012 113 124
85. B.M. Gallagher Jr. Microtubule-stabilizing natural products as promising cancer therapeutics Curr. Med. Chem. 14 28 2007 2959 2967
86. K.D. Park, and S.J. Cho Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism Eur. J. Med. Chem. 45 3 2010 1028 1033
87. X. Wang, A. Zhang, Y. Han, P. Wang, H. Sun, G. Song, T. Dong, Y. Yuan, X. Yuan, M. Zhang, X. Ning, H. Zhang, H. Dong, and W. Dong Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease Mol. Cell. Proteomics. 2012 PMID:22505723
88. M. Bordoloi, R. Kotoky, J.J. Mahanta, T.C. Sarma, and P.B. Kanjilal Anti-genotoxic hydrazide from Crinum defixum Eur. J. Med. Chem. 44 6 2009 2754 2757
89. G. Bringmann, G. Zhang, A. Hager, M. Moos, A. Irmer, R. Bargou, and M. Chatterjee Anti-tumoral activities of dioncoquinones B and C and related naphthoquinones gained from total synthesis or isolation from plants Eur. J. Med. Chem. 46 12 2011 5778 5789
90. L. Wang, G.B. Zhou, P. Liu, J.H. Song, Y. Liang, X.J. Yan, F. Xu, B.S. Wang, J.H. Mao, Z.X. Shen, S.J. Chen, and Z. Chen Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia Proc. Natl. Acad. Sci. U S A 105 12 2008 4826 4831